‘Problem’ excipients: be cautious when making clinical decisions on formulation
We are writing in response to the article ‘How to identify and manage ‘problem’ excipients in medicines for children’, written by Sara Arthur and Anna Burgess and published in The Pharmaceutical Journal (2017;299(7903):42–45). The article helpfully raises aw…
